https://m2.mtmt.hu/ hun 2026-09-23 04:47 JournalArticle 32030019 VALIDATED true University of Belgrade Faculty of Medicine, Faculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia Semmelweis University Department of Pharmacology and Pharmacotherapy, Budapest, Hungary University of Belgrade, Faculty of Dentistry, Belgrade, Serbia University of Novi Sad Faculty of Technical Sciences, Novi Sad, Serbia Pharmahungary Group, Szeged, Hungary Cited By :2 Export Date: 8 May 2023 CODEN: TXAPA Correspondence Address: Japundžić-Žigon, N.; Institute of Pharmacology, Serbia; email: nina.zigon@med.bg.ac.rs 0 false 2026-08-10T20:25:31.938+0000 2024-09-17T08:01:22.823+0000 2021-05-21T18:12:19.349+0000 true 10010125 Ferdinandy Péter /api/author/10010125 Author Ferdinandy Péter (Farmakológia, molekuláris medicina) true 10010125 2024-09-17T08:01:23.451+0000 2024-09-17T08:01:23.451+0000 2022-02-16T10:20:32.374+0000 true 10062250 Molnár-Taga Márta /api/admin/10062250 Admin Molnár-Taga Márta (SE 4-es admin) true 10062250 Admin 10073918 /api/admin/10073918 Kovács Marcell (MTMT Közp., admin) Kovács Marcell true true 2024-09-09T07:21:55.189+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Pajović, Vladislav true true /api/journal/4288 REVIEWED TOXICOLOGY AND APPLIED PHARMACOLOGY 0041-008X 1096-0333 true false 4288 false 4288 true 0041-008X 1096-0333 Journal FOREIGN 423 115579 115579 11 2021 Funding 2009819 /api/funding/2009819 ((NKFIH) [VEKOP-2.3.2-16-2016-00002) Támogató: NKFIH false true Funding 2009820 /api/funding/2009820 (TÉT_16-1-2016- 0057) false true true true 2021 true true true false true false NONE 2026-08-10 false 9 0 9 7 0 9 9 8 8 9 9 7 7 7 2 0 9 7 9 7 0 2 2 Folyóiratcikk Journal Article 24 9 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2022 0 3 2 3 2 2023 0 2 2 2 2 2024 0 2 2 2 2 2025 0 1 0 1 0 2026 0 1 1 1 1 Q1 false false false false 2021-05-27T17:53:26.568+0000 Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 4 22 1 10 0 true 10073918 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 96374666 /api/authorship/96374666 Pajović, Vladislav 1 0.1 true false false Pajović Vladislav true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374667 /api/authorship/96374667 Kovácsházi, Csenger [Kovácsházi, Csenger (Gyógyszertudomány), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 2 0.1 false false false Author 10069239 /api/author/10069239 Kovácsházi Csenger (Gyógyszertudomány) Kovácsházi Csenger true true Kovácsházi Csenger true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374668 /api/authorship/96374668 Kosić, Marija 3 0.1 false false false Kosić Marija true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374669 /api/authorship/96374669 Vasić, Marko 4 0.1 false false false Vasić Marko true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374670 /api/authorship/96374670 Đukić, Ljiljana 5 0.1 false false false Đukić Ljiljana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374671 /api/authorship/96374671 Brenner, Gábor B. [Brenner, Gábor (Kardiovaszkuláris...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 6 0.1 false false false Author 10052112 /api/author/10052112 Brenner Gábor (Kardiovaszkuláris farmakológia) Brenner Gábor true 10052112 true Brenner Gábor B. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374672 /api/authorship/96374672 Giricz, Zoltán [Giricz, Zoltán (Biokémia, Farmako...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 7 0.1 false false false Author 10026898 /api/author/10026898 Giricz Zoltán (Biokémia, Farmakológia) Giricz Zoltán true 10026898 true Giricz Zoltán true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374673 /api/authorship/96374673 Bajić, Dragana 8 0.1 false false false Bajić Dragana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374674 /api/authorship/96374674 Ferdinandy, Péter [Ferdinandy, Péter (Farmakológia, mol...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I) 9 0.1 false false false Author 10010125 /api/author/10010125 Ferdinandy Péter (Farmakológia, molekuláris medicina) Ferdinandy Péter true 10010125 true Ferdinandy Péter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 96374675 /api/authorship/96374675 Japundžić-Žigon, Nina ✉ 10 0.1 false true true Japundžić-Žigon Nina true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 18824146 /api/publicationidentifier/18824146 DOI: 10.1016/j.taap.2021.115579 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.taap.2021.115579 https://doi.org/10.1016/j.taap.2021.115579 false true PublicationIdentifier 19036456 /api/publicationidentifier/19036456 WoS: 000662666000001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 000662666000001 https://www.webofscience.com/wos/woscc/full-record/000662666000001 false true PublicationIdentifier 18917006 /api/publicationidentifier/18917006 Scopus: 85106367851 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85106367851 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85106367851 false true PublicationIdentifier 18824147 /api/publicationidentifier/18824147 PubMed: 34015281 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 34015281 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34015281&dopt=Abstract false true Classification 12184 /api/classification/12184 Farmakológia és gyógyszerészet true true Classification 10572 /api/classification/10572 Toxikológia true true SjrRating 11238382 /api/sjrrating/11238382 sjr:Q1 (2021) Scopus - Toxicology TOXICOLOGY AND APPLIED PHARMACOLOGY 0041-008X 1096-0333 24 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 3005 /api/classificationexternal/3005 Scopus - Toxicology true 3005 true Q1 DIRECT true true Reference 20732441 /api/reference/20732441 1. Cardinale 2004: Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy, Circulation, 109, p. 2749, DOI: 10.1161/01.CIR.0000130926.51766.CC 1 10.1161/01.CIR.0000130926.51766.CC false true Reference 20732442 /api/reference/20732442 2. Cerutti 1991: Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach, Am. J. Phys., 261, p. H1292 2 false true Reference 20732443 /api/reference/20732443 3. Cerutti 1994: Baroreflex modulation of blood pressure and heart rate variabilities in rats: assessment by spectral analysis, Am. J. Phys., 266 3 false true Reference 20732444 /api/reference/20732444 4. Cheah 2017: Hemodynamic effects of HPMA copolymer based doxorubicin conjugate: a randomized controlled and comparative spectral study in conscious rats, Nanotoxicology, 11, p. 210, DOI: 10.1080/17435390.2017.1285071 4 10.1080/17435390.2017.1285071 false true Reference 20732445 /api/reference/20732445 5. Dhar 2016: Targeted myocardial gene expression in failing hearts by RNA sequencing, J. Transl. Med., 14, p. 327, DOI: 10.1186/s12967-016-1083-6 5 10.1186/s12967-016-1083-6 false true Reference 20732446 /api/reference/20732446 6. Dharmani 2007: Effects of angiotensin 1-7 on the actions of angiotensin II in the renal and mesenteric vasculature of hypertensive and streptozotocin-induced diabetic rats, Eur. J. Pharmacol., 561, p. 144, DOI: 10.1016/j.ejphar.2007.01.037 6 10.1016/j.ejphar.2007.01.037 false true Reference 20732447 /api/reference/20732447 7. Fred 2005: Combining multiple Clusterings using evidence accumulation, IEEE Trans. Pattern Anal. Mach. Intell., 27, p. 835, DOI: 10.1109/TPAMI.2005.113 7 10.1109/TPAMI.2005.113 false true Reference 20732448 /api/reference/20732448 8. Frey 2007: Clustering by passing messages between data points, Science, 315, p. 972, DOI: 10.1126/science.1136800 8 10.1126/science.1136800 false true Reference 20732449 /api/reference/20732449 9. Grace 2013: Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis, Gastroenterology, 145, p. 874, DOI: 10.1053/j.gastro.2013.06.036 9 10.1053/j.gastro.2013.06.036 false true Reference 20732450 /api/reference/20732450 10. Haas 1995: Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model, Am. Heart J., 130, p. 806, DOI: 10.1016/0002-8703(95)90081-0 10 10.1016/0002-8703(95)90081-0 false true Reference 20732451 /api/reference/20732451 11. Herin 2003: Different vascular responsiveness to angiotensin II in two normotensive rat strains, Fundam. Clin. Pharmacol., 17, p. 315, DOI: 10.1046/j.1472-8206.2003.00145.x 11 10.1046/j.1472-8206.2003.00145.x false true Reference 20732452 /api/reference/20732452 12. Jain 1988 12 false true Reference 20732453 /api/reference/20732453 13. Japundzic 1990: Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers, J. Auton. Nerv. Syst., 30, p. 91, DOI: 10.1016/0165-1838(90)90132-3 13 10.1016/0165-1838(90)90132-3 false true Reference 20732454 /api/reference/20732454 14. Japundzic-Zigon 1998: Physiological mechanisms in regulation of blood pressure fast frequency variations, Clin. Exp. Hypertens., 20, p. 359, DOI: 10.3109/10641969809053219 14 10.3109/10641969809053219 false true Reference 20732455 /api/reference/20732455 15. Japundzic-Zigon 2001: Effects of nonpeptide V1a and V2 antagonists on blood pressure fast oscillations in conscious rats, Clin. Exp. Hypertens., 23, p. 277, DOI: 10.1081/CEH-100102667 15 10.1081/CEH-100102667 false true Reference 20732456 /api/reference/20732456 16. Japundzić-Zigon 2004: Effects of nonpeptide and selective V1 and V2 antagonists on blood pressure short-term variability in spontaneously hypertensive Rats, J. Pharmacol. Sci., 95, p. 47, DOI: 10.1254/jphs.95.47 16 10.1254/jphs.95.47 false true Reference 20732457 /api/reference/20732457 17. Japundžić-Žigon 2018: Sudden death: neurogenic causes, prediction and prevention, Eur. J. Prev. Cardiol., 25, p. 29, DOI: 10.1177/2047487317736827 17 10.1177/2047487317736827 false true Reference 20732458 /api/reference/20732458 18. Jensen 1984: Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects, J. Cardiovasc. Pharmacol., 6, p. 186, DOI: 10.1097/00005344-198401000-00028 18 10.1097/00005344-198401000-00028 false true Reference 20732459 /api/reference/20732459 19. Lončar-Turukalo 2015: Heart rate dynamics in doxorubicin-induced cardiomyopathy, Physiol. Meas., 36, p. 727, DOI: 10.1088/0967-3334/36/4/727 19 10.1088/0967-3334/36/4/727 false true Reference 20732460 /api/reference/20732460 20. Lozić 2014: Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats, Br. J. Pharmacol., 171, p. 4385, DOI: 10.1111/bph.12776 20 10.1111/bph.12776 false true Reference 20732461 /api/reference/20732461 21. Lozić 2016: Over-expression of V1A receptors in PVN modulates autonomic cardiovascular control, Pharmacol. Res., 114, p. 185, DOI: 10.1016/j.phrs.2016.10.024 21 10.1016/j.phrs.2016.10.024 false true Reference 20732462 /api/reference/20732462 22. McLachan 1989 22 false true Reference 20732463 /api/reference/20732463 23. Milutinović 2006: The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study, Am. J. Phys. Regul. Integr. Comp. Phys., 291, p. R1579 23 false true Reference 20732464 /api/reference/20732464 24. Milutinović 2006: Central cholinergic modulation of blood pressure short-term variability, Neuropharmacology, 50, p. 874, DOI: 10.1016/j.neuropharm.2005.12.009 24 10.1016/j.neuropharm.2005.12.009 false true Reference 20732465 /api/reference/20732465 25. Onoda 2012: Careful seeding method based on independent components analysis for k-means clustering, J. Emerg. Technol. Web Intell., 4, p. 51 25 false true Reference 20732466 /api/reference/20732466 26. Oz 1995: Insight into blood-pressure control in SHR via the response to acute hemorrhage: a spectral analysis approach, J. Auton. Nerv. Syst., 55, p. 146, DOI: 10.1016/0165-1838(95)00044-X 26 10.1016/0165-1838(95)00044-X false true Reference 20732467 /api/reference/20732467 27. Perazella 2009: Renal vulnerability to drug toxicity, Clin. J. Am. Soc. Nephrol., 4, p. 1275, DOI: 10.2215/CJN.02050309 27 10.2215/CJN.02050309 false true Reference 20732468 /api/reference/20732468 28. Pfeffer 2019: Hear failure with preserved ejection fraction: in perspective, Circ. Res., 124, p. 1598, DOI: 10.1161/CIRCRESAHA.119.313572 28 10.1161/CIRCRESAHA.119.313572 false true Reference 20732469 /api/reference/20732469 29. Ponchon 1996: Contribution of the renin-angiotensin and Kallikrein-Kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats, Eur. J. Pharmacol., 297, p. 61, DOI: 10.1016/0014-2999(95)00721-0 29 10.1016/0014-2999(95)00721-0 false true Reference 20732470 /api/reference/20732470 30. Ponikowski 2016: Eur. J. Heart Fail., 18, p. 891, DOI: 10.1002/ejhf.592 30 10.1002/ejhf.592 false true Reference 20732471 /api/reference/20732471 31. Robison 1986: Effect of chronic Administration of Doxorubicin on cardiac Adenylate Cyclase activity in mice, Biochem. Biophys. Res. Commun., 136, p. 745, DOI: 10.1016/0006-291X(86)90502-4 31 10.1016/0006-291X(86)90502-4 false true Reference 20732472 /api/reference/20732472 32. Russo 2021: Metabolic aspects of anthracycline cardiotoxicity, Curr. Treat. Options in Oncol., 22, p. 18, DOI: 10.1007/s11864-020-00812-1 32 10.1007/s11864-020-00812-1 false true Reference 20732473 /api/reference/20732473 33. Šarenac 2011: 2011. Autonomic mechanisms underpinning the stress response in borderline hypertensive rats, Exp. Physiol., 96, p. 574, DOI: 10.1113/expphysiol.2010.055970 33 10.1113/expphysiol.2010.055970 false true Reference 20732474 /api/reference/20732474 34. Sarhene 2019: Biomarkers in heart failure: the past, current and future, Heart Fail. Rev., 24, p. 867, DOI: 10.1007/s10741-019-09807-z 34 10.1007/s10741-019-09807-z false true Reference 20732475 /api/reference/20732475 35. Stauss 2000: Blood pressure control in eNOS Knock-out mice: comparison with other species under NO blockade, Acta Physiol. Scand., 168, p. 155, DOI: 10.1046/j.1365-201x.2000.00639.x 35 10.1046/j.1365-201x.2000.00639.x false true Reference 20732476 /api/reference/20732476 36. Stojicić 2008: Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats, Neuropharmacology, 54, p. 824, DOI: 10.1016/j.neuropharm.2007.12.013 36 10.1016/j.neuropharm.2007.12.013 false true Reference 20732477 /api/reference/20732477 37. Tannenbaum 2015: Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction, Curr. Opin. Cardiol., 30, p. 250, DOI: 10.1097/HCO.0000000000000163 37 10.1097/HCO.0000000000000163 false true Reference 20732478 /api/reference/20732478 38. Tocchetti 2019: From molecular mechanisms to clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: a translational overview, Antioxid. Redox Signal., 30, p. 2110, DOI: 10.1089/ars.2016.6930 38 10.1089/ars.2016.6930 false true Reference 20732479 /api/reference/20732479 39. Tromp 2017: Cardio-oncology: progress in diagnosis and treatment of cardiac dysfunction, Clin. Pharmacol. Ther., 101, p. 481, DOI: 10.1002/cpt.614 39 10.1002/cpt.614 false true Reference 20732480 /api/reference/20732480 40. van der Maaten 2012: Visualizing non-metric similarities in multiple maps, Mach. Learn., 87, p. 33, DOI: 10.1007/s10994-011-5273-4 40 10.1007/s10994-011-5273-4 false true Reference 20732481 /api/reference/20732481 41. Varga 2015: Drug-induced mitochondrial dysfunction and cardiotoxicity, Am. J. Physiol. Heart Circ. Physiol., 309, p. H1453, DOI: 10.1152/ajpheart.00554.2015 41 10.1152/ajpheart.00554.2015 false true Reference 20732482 /api/reference/20732482 42. Vasić 2019: Cardiovascular variability and β-ARs gene expression at two stages of doxorubicin - induced cardiomyopathy, Toxicol. Appl. Pharmacol., 362, p. 43, DOI: 10.1016/j.taap.2018.10.015 42 10.1016/j.taap.2018.10.015 false true Reference 20732483 /api/reference/20732483 43. Yamada 2012: Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury, Free Radic. Biol. Med., 52, p. 1285, DOI: 10.1016/j.freeradbiomed.2012.02.003 43 10.1016/j.freeradbiomed.2012.02.003 false true Reference 20732484 /api/reference/20732484 44. Yamada 2016: Involvement of intracellular cAMP in epirubicin-induced vascular endothelial cell injury, J. Pharmacol. Sci., 130, p. 33, DOI: 10.1016/j.jphs.2015.12.010 44 10.1016/j.jphs.2015.12.010 false true /api/publication/32030019 Pajović Vladislav et al. Phenomapping for classification of doxorubicin-induced cardiomyopathy in rats. (2021) TOXICOLOGY AND APPLIED PHARMACOLOGY 0041-008X 1096-0333 423<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" >Pajović Vladislav </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10069239"><a href="/gui2/?type=authors&mode=browse&sel=10069239" target="_blank">Kovácsházi Csenger (<span class="authorship-author-name">Kovácsházi Csenger</span> <span class="authorAux-mtmt"> Gyógyszertudomány</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kosić Marija </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Vasić Marko </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Đukić Ljiljana </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10052112"><a href="/gui2/?type=authors&mode=browse&sel=10052112" target="_blank">Brenner Gábor B. (<span class="authorship-author-name">Brenner Gábor</span> <span class="authorAux-mtmt"> Kardiovaszkuláris farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10026898"><a href="/gui2/?type=authors&mode=browse&sel=10026898" target="_blank">Giricz Zoltán (<span class="authorship-author-name">Giricz Zoltán</span> <span class="authorAux-mtmt"> Biokémia, Farmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Bajić Dragana </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10010125"><a href="/gui2/?type=authors&mode=browse&sel=10010125" target="_blank">Ferdinandy Péter (<span class="authorship-author-name">Ferdinandy Péter</span> <span class="authorAux-mtmt"> Farmakológia, molekuláris medicina</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Japundžić-Žigon Nina ✉ </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;32030019" target="_blank">Phenomapping for classification of doxorubicin-induced cardiomyopathy in rats</a></div> <div> <span class="journal-title">TOXICOLOGY AND APPLIED PHARMACOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0041-008X">0041-008X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1096-0333">1096-0333</a>)</span>: <span class="journal-volume">423</span> <span class="page"> Paper 115579. 11 p. </span> <span class="year">(2021)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.taap.2021.115579" target="_blank" href="https://doi.org/10.1016/j.taap.2021.115579"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000662666000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000662666000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85106367851" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85106367851"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="34015281" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=34015281&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Toxicology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pharmacology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 9</span> | Független: 7 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 8 | Scopus jelölt:&nbsp;8 | WoS/Scopus jelölt:&nbsp;9 | DOI jelölt:&nbsp;9 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;32030019&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 2 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 32030019</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (VEKOP-2.3.2-16-2016-00002) Támogató: NKFIH, (TÉT_16-1-2016- 0057) </div> <div class="lastModified">Utolsó módosítás: 2024.09.17. 10:01 Kovács Marcell (MTMT Közp., admin) </div> <div class="lockedBy">Központi kezelésű 2024.09.09. 09:21 Kovács Marcell (MTMT Közp., admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: University of Belgrade Faculty of Medicine, Faculty of Medicine, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Belgrade, Serbia Semmelweis University Department of Pharmacology and Pharmacotherapy, Budapest, Hungary University of Belgrade, Faculty of Dentistry, Belgrade, Serbia University of Novi Sad Facu...</pre> </div></div>